The human cytomegalovirus chemokine binding protein UL22A is necessary for efficient reactivation from latency in CD34 + hematopoietic progenitor cells and humanized mice
Open Access
- 18 August 2026
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (8)
Abstract
Herpesviruses and poxviruses encode secreted chemokine binding proteins that prevent the interaction between chemokines and their cognate G protein-coupled receptors to alter chemotactic gradients and intracellular signaling pathways. Human cytomegalovirus (HCMV) encodes the secreted protein UL22A (formerly UL21.5), which is described as a CCL5 (RANTES) binding protein and requires sulfation at two tyrosine residues (Y65 and Y69) for efficient RANTES interaction. In this report, we show that the UL22A protein and the UL22A Y65 and Y69 residues are necessary for efficient HCMV reactivation from latency in CD34 + hematopoietic progenitor cells and that UL22A expression is essential for reactivation in a humanized mouse model of latency. However, RANTES neutralization is not sufficient to complement the in vitro reactivation defect of UL22A mutant viruses. These data suggest that UL22A plays an important role in latency, possibly through interactions with additional chemokines or other types of ligands via its tyrosine residues in order to mediate efficient HCMV reactivation. IMPORTANCE: Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that infects 60%–90% of the population worldwide. In immunocompetent individuals, primary infection is asymptomatic and results in lifelong latent infection in CD34 + hematopoietic progenitor cells. Viral reactivation remains a major complication for immunosuppressed individuals, but current therapeutics targeting HCMV replication show significant toxicity. Thus, a better understanding of the mechanisms controlling latency and reactivation is necessary to develop new therapeutics targeting these stages of the HCMV lifecycle. UL22A is a chemokine-binding protein encoded by HCMV. Viral chemokine-binding proteins help regulate the host immune response and promote virus replication. We show that UL22A and its Y65 and Y69 residues are necessary for reactivation from latency in CD34 + hematopoietic progenitor cells and in a humanized mouse model. Additionally, we show that UL22A binding to its only known chemokine partner, RANTES (regulated on activation, normal T cell expressed and secreted), is not necessary for this reactivation phenotype. These findings suggest other novel functions for UL22A that we do not yet understand.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI21640)
- National Institute of Allergy and Infectious Diseases (P01AI127335)
- National Institutes of Health (T32AI170496)
This publication has 65 references indexed in Scilit:
- Regulation of hematopoiesis by the chemokine systemCytokine, 2018
- Sulfation of the Human Cytomegalovirus Protein UL22A Enhances Binding to the Chemokine RANTESAngewandte Chemie International Edition, 2017
- Humanized mouse models of human cytomegalovirus infectionCurrent Opinion in Virology, 2015
- Hematopoietic Long-Term Culture (hLTC) for Human Cytomegalovirus Latency and Reactivation2014
- Heteromerization of human cytomegalovirus encoded chemokine receptorsBiochemical Pharmacology, 2011
- Granulocyte-Colony Stimulating Factor Reactivates Human Cytomegalovirus in a Latently Infected Humanized Mouse ModelCell Host & Microbe, 2010
- Modulation of chemokine activity by virusesCurrent Opinion in Immunology, 2010
- Monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1Cytokine, 2008
- Sequence variability of the α‐chemokine UL146 from clinical strains of human cytomegalovirusJournal of Medical Virology, 2004
- The Cytomegalovirus US28 Protein Binds Multiple CC Chemokines with High AffinityBiochemical and Biophysical Research Communications, 1995